Cardiac cGMP-stimulated cyclic nucleotide phosphodiesterases: effects of cGMP analogues and drugs

This publication has 26 references indexed in Scilit:

• Specificity of Cyclic GMP Activation of a Multi-substrate Cyclic Nucleotide Phosphodiesterase from Rat Liver
  European Journal of Biochemistry, 2005
• Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells
  Biochemical Pharmacology, 1990
• Differential Sensitivity to Cardiotonic Drugs of Cyclic AMP Phosphodiesterases Isolated from Canine Ventricular and Sinoatrial-Enriched Tissues
  Journal of Cardiovascular Pharmacology, 1989
• Subcellular distribution of high-affinity type IV cyclic AMP phosphodiesterase activity in rabbit ventricular myocardium: relations to the effects of cardiotonic drugs.
  Circulation Research, 1988
• Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells
  Nature, 1986
• Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta
  Biochemical Pharmacology, 1986
• Cyclic nucleotide specificity of the activator and catalytic sites of a cGMP‐stimulated cGMP phosphodiesterase from Dictyostelium discoideum
  European Journal of Biochemistry, 1985
• Effect of native and synthetic atrial natriuretic factor on cyclic GMP
  Biochemical and Biophysical Research Communications, 1984
• Cyclic AMP and cyclic GMP may play opposing roles in influencing force of contraction in mammalian myocardium
  Nature, 1976
• Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
  Biochemical Pharmacology, 1973